Common Contracts
2 similar Clinical Trial Agreement contracts
Celgene International SarlClinical Trial Agreement • March 2nd, 2016
CLINICAL TRIAL AGREEMENT ZMLUVA O KLINICKOM SKÚŠANÍ for Protocol GED-0301-UC-002 pre Protokol GED-0301-UC-002 This Clinical Trial Agreement (hereinafter, the“Agreement”) is by and between: Táto zmluva o klinickom skúšaní (ďalej iba „zmluva“) sauzatvára medzi: Celgene Corporation, having its principal office at 86 Morris Avenue, Summit, NJ 07901, USA (hereinafter called “Sponsor”) represented for the purposes of this Agreement by Celgene International S.à.r.l, a limited liability company organized under the laws of Switzerland having its principal office at Route de Perreux, 2017 Boudry, Switzerland and by PPD Investigator Services LLC, only for the purposes of signing this Agreement in the name of the Sponsor, a company organized under the laws of the State of Delaware having its principal office at 929 North FrontStreet, Wilmington NC 28401, USA spoločnosťou Celgene Corporation so sídlom správnej rady na adrese 86 Morris Avenue, Summit, NJ 07901, USA (ďalej iba „zadávateľ“), k
Celgene International SarlClinical Trial Agreement • November 4th, 2015
CLINICAL TRIAL AGREEMENT ZMLUVA O KLINICKOM SKÚŠANÍ for Protocol GED-0301-CD-001 pre Protokol GED-0301-CD-001 This Clinical Trial Agreement (hereinafter, the“Agreement”) is by and between: Táto zmluva o klinickom skúšaní (ďalej iba „zmluva“) sauzatvára medzi: Celgene Corporation, having its principal office at 86 Morris Avenue, Summit, NJ 07901, USA (hereinafter called “Sponsor”) represented for the purposes of this Agreement by Celgene International S.à.r.l, a limited liability company organized under the laws of Switzerland having its principal office at Route de Perreux, 2017 Boudry, Switzerland and by PPD Investigator Services LLC, only for the purposes of signing this Agreement in the name of the Sponsor, a company organized under the laws of the State of Delaware having its principal office at 929 North FrontStreet, Wilmington NC 28401, USA spoločnosťou Celgene Corporation so sídlom správnej rady na adrese 86 Morris Avenue, Summit, NJ 07901, USA (ďalej iba „zadávateľ“), k
